Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cross Country Healthcare (CCRN) EBITDA Margin (2016 - 2025)

Cross Country Healthcare (CCRN) has disclosed EBITDA Margin for 16 consecutive years, with 14606.16% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin rose 1460739.0% year-over-year to 14606.16%, compared with a TTM value of 11.62% through Dec 2025, down 1054.0%, and an annual FY2025 reading of 4285.69%, up 428678.0% over the prior year.
  • EBITDA Margin was 14606.16% for Q4 2025 at Cross Country Healthcare, up from 1.94% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 14606.16% in Q4 2025 and bottomed at 4.72% in Q2 2024.
  • Average EBITDA Margin over 5 years is 733.26%, with a median of 3.71% recorded in 2023.
  • The sharpest move saw EBITDA Margin plummeted -867bps in 2024, then skyrocketed 1460739bps in 2025.
  • Year by year, EBITDA Margin stood at 12.11% in 2021, then tumbled by -49bps to 6.17% in 2022, then crashed by -65bps to 2.19% in 2023, then tumbled by -156bps to 1.23% in 2024, then skyrocketed by 1192366bps to 14606.16% in 2025.
  • Business Quant data shows EBITDA Margin for CCRN at 14606.16% in Q4 2025, 1.94% in Q3 2025, and 2.43% in Q2 2025.